Hemostasis and fibrinolysis in COVID‐19 survivors 6 months after intensive care unit discharge

Hemostasis and fibrinolysis in COVID‐19 survivors 6 months after intensive care unit discharge

Abstract Background The prothrombotic phenotype has been extensively described in patients with acute coronavirus disease 2019 (COVID‐19). However, potential long‐term hemostatic abnormalities are unknown. Objective To evaluate the changes in routine hemostasis laboratory parameters and tissue‐type...

Full description

Bibliographic Details
Main Authors: Anne‐Marije Hulshof, Dionne C. W. Braeken, Chahinda Ghossein‐Doha, Susanne van Santen, Jan‐Willem E. M. Sels, Gerhardus J. A. J. M. Kuiper, Iwan C. C. van der Horst, Hugo ten Cate, Bas C. T. vanBussel, Renske H. Olie, Yvonne M. C. Henskens
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
COVID‐19
fibrinolysis
follow‐up studies
hemostasis
thromboelastography
Online Access:https://doi.org/10.1002/rth2.12579

Internet

https://doi.org/10.1002/rth2.12579

Similar Items